15 The study found that GLP-1 medication was associated with an 18% relative reduction in risk of developing any AMD from no AMD at baseline: 0.46% of the GLP-1 group had any AMD after 10 years, while 0.55% had any AMD in the control group
Additional Considerations for Women of Reproductive Age Using Tirzepatide When using tirzepatide, women of reproductive age have special health factors to consider, especially around birth control, pregnancy planning, and reproductive health
Both selective AMYR agonists, and dual CTR and AMYR agonists such as sCT 5,6,7 , have demonstrated efficacy in controlling appetite and body weight, however this is not seen with a CTR-selective agonist 9
In its March 2026 strategic shift, the company moved its weight-loss business to commercially available FDA-approved GLP-1s and now sells brand-name Wegovy (both the injectable pen and the new oral pill), Ozempic, and Zepbound
About Wegovy and Ozempic
Additional glycemic control is needed, increase the dosage to 14 mg orally once daily